TMCI - Treace Medical Concepts, Inc.
NasdaqGS - NasdaqGS 即時價格。貨幣為 USD。
收市：04:00PM EDT
收市後：
你目前的瀏覽器並不支援股價圖表
| 前收市價 | 26.25 |
| 開市 | 26.25 |
| 買盤 | 0.00 x 900 |
| 賣出價 | 0.00 x 900 |
| 今日波幅 | 25.88 - 26.65 |
| 52 週波幅 | 13.19 - 27.97 |
| 成交量 | |
| 平均成交量 | 384,961 |
| 市值 | 1.61B |
| Beta 值 (5 年，每月) | -0.01 |
| 市盈率 (最近 12 個月) | 無 |
| 每股盈利 (最近 12 個月) | -0.85 |
| 業績公佈日 | 2023年8月07日 - 2023年8月11日 |
| 遠期股息及收益率 | 無 (無) |
| 除息日 | 無 |
| 1 年預測目標價 | 30.40 |
BenzingaTreace Medical Shares Interim Data From Corrective Toe Surgery Trial
Treace Medical Concepts Inc (NASDAQ: TMCI) announced an audio poster presentation of the latest interim analysis from the ALIGN3D clinical study following the Lapiplasty Procedure for surgical treatment of hallux valgus (bunions). The data showed: Early return to weight bearing in a walking boot at an average of 8.3 days. A low recurrence rate, defined as loss of radiographic correction, was observed in 1.4% of patients (2 out of 144). An 81% reduction in pain (Visual Analog Scale) was reported